Pata Rama Kanth, Bastola Chhabilal, Nway Nway, Patel Meet J, Adhikari Samaj
Pulmonary Medicine, Interfaith Medical Center, Brooklyn, USA.
Internal Medicine, Interfaith Medical Center, Brooklyn, USA.
Cureus. 2021 Mar 30;13(3):e14183. doi: 10.7759/cureus.14183.
Augmented renal clearance (ARC) is a unique clinical scenario observed in critically ill patients. We present a case of a 30-year-old male with sepsis secondary to methicillin-resistant Staphylococcus aureus (MRSA) bacteremia treated with vancomycin. ARC was observed in the patient with a maximum estimated glomerular filtration rate (eGFR) of 161.9 ml/min/1.73 m, and therapeutic drug monitoring was used to adjust the vancomycin dosage. Despite the maximal recommended dose of vancomycin, the therapeutic vancomycin level was not achieved, leading to treatment failure and subsequent mortality. Our case report suggests the necessity of other strategies, such as early dose adjustment of vancomycin based on vancomycin clearance and continuous vancomycin infusion, not merely conventional adjustment based on eGFR and vancomycin levels.
肾脏清除率增加(ARC)是危重症患者中观察到的一种独特临床情况。我们报告一例30岁男性,因耐甲氧西林金黄色葡萄球菌(MRSA)菌血症继发脓毒症,接受万古霉素治疗。该患者出现ARC,最大估算肾小球滤过率(eGFR)为161.9 ml/min/1.73 m²,采用治疗药物监测来调整万古霉素剂量。尽管使用了最大推荐剂量的万古霉素,但仍未达到治疗性万古霉素水平,导致治疗失败及随后的死亡。我们的病例报告提示需要采取其他策略,如根据万古霉素清除率早期调整万古霉素剂量以及持续输注万古霉素,而不仅仅是基于eGFR和万古霉素水平进行常规调整。